Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Shorts Are Piling Into These Stocks. Should You Be Worried?: Quiksilver, Inc. (ZQK) and More

Page 1 of 2

The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term. But when you look at individual stocks, you’ll find plenty that lose money over the long haul. According to hedge-fund institution Blackstar Funds, even with dividends included, between 1983 and 2006, 64% of stocks underperformed the Russell 3000, a broad-scope market index.

Quiksilver, Inc. (NYSE:ZQK)A large influx of short-sellers shouldn’t be a condemning factor to any company, but it could be a red flag from traders that something may not be as cut-and-dried as it appears. Let’s look at three companies that have seen a rapid increase in the amount of shares sold short and see whether traders are blowing smoke, or if their worry has some merit.

Company Short Increase Jan. 15 to Jan. 31 Short Shares as a % of Float
Quiksilver, Inc. (NYSE:ZQK) 67.2% 9%
Constellation Brands (NYSE:STZ) 59.9% 3%
Noble (NYSE:NE) 55.6% 2%

Source: The Wall Street Journal.

Headed for a wipeout?
The surf may be up, but investors could be headed for a wipeout at surf-and-skate apparel retailer Quiksilver. Shares of Quiksilver have tripled since its lows of last summer as the company has changed CEOs, cut expenses, beefed up marketing, and introduced new apparel styles in its stores. Unfortunately, the holiday season wasn’t very kind to action-sports retailers, which should necessitate caution from shareholders going forward.

The long struggling Pacific Sunwear of California, Inc. (NASDAQ:PSUN), which is a direct competitor to the surf-and-skate clothing that Quiksilver offers, reported a 1% increase in its fiscal fourth-quarter sales in January, but noted that its peak sales occurred during its highest levels of promotional activity — clearly not what PacSun wanted or expected. I expect much of the same from Quiksilver, which has had to pinch pennies and reduce prices in order to keep customers coming into the store.

Another disconcerting factor is Quiksilver’s reliance on the U.S. and European markets. Although Asia demonstrated sales growth of 13% in the fourth quarter, this high-growth region accounts for just 15% of total sales. With U.S. retail sales growth expected to take a hit from the end of the payroll tax holiday and Europe’s sales expected to recede further from austerity measures, I’d give short-sellers a clean bill of health to short away.

This liquor is quicker
Shareholders of alcohol producer Constellation Brands are still feeling the buzz of its meteoric 37% rise two weeks ago after announcing that it had agreed to purchase its remaining interests of Grupo Modelo‘s Piedras Negras brewery, and all U.S. rights, for $2.9 billion.

The original deal that necessitated this purchase on the cheap by Constellation was a purchase of Grupo Modelo by Anheuser-Busch InBev NV (ADR) (NYSE:BUD). Constellation had a working interest in the existing Piedras Negras plant, but a lawsuit filed by U.S. regulators to stop the merger based on the fact that it wouldn’t give Anheuser-Busch enough competition and would discourage innovation nearly killed the original deal. Constellation’s $2.9 billion purchase will allow it to expand its U.S. presence for a very reasonable price and will allow Anheuser-Busch to proceed with its purchase of the remaining pieces of Grupo Modelo.

Constellation may seem a bit pricey at 15 times forward earnings following the announcement of the deal, but the sheer market share it could gain from this purchase more than negates its near-term price. Short-sellers have already been burned once and I wouldn’t suggest a continued downside bet with momentum on Constellation’s side.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!